Nomura Securities Starts Galapagos NV (GLPG) at Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/24/2026
- S&P 500, Nasdaq end down on tech stocks, investors weigh Iran moves
- Oil drops more than $2 despite new US sanctions on Iran
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- Wattmore and Eos Energy strike non-exclusive storage software deal
- Grand Canyon Education places CFO on leave amid stock trade probe
- S&P 500, Nasdaq end down on tech stocks, investors weigh Iran moves
- Funds sell $44bn in semiconductors on AI concerns
- RUM Group signs $13.7 billion GPU services deal, issues warrants
Credit Suisse Starts Galapagos NV (GLPG) at Outperform
June 8, 2015 8:27 AM EDTCredit Suisse initiates coverage on Galapagos NV (NASDAQ: GLPG) with a Outperform rating with a EUR61 price target.
Analyst Vamil Divan, "We view Galapagos as a leading clinical-stage biotechnology company that is well positioned to deliver strong long-term growth from its proprietary siRNA discovery... More
Cowen Starts Galapagos NV (GLPG) at Outperform
June 8, 2015 6:41 AM EDTCowen initiates coverage on Galapagos NV (NASDAQ: GLPG) with a Outperform rating.
Analyst Phil Nadeau commented, "Galapagos has advanced a broad and deep pipeline into clinical development, with four candidates currently in clinical testing. Filgotinib has produced impressive results in Ph. IIb trials in... More
